Trevi Therapeutics, Inc. (TRVI)
Nasdaq: TRVI · Pharmaceutical Preparations · New Haven, CT · filing with the SEC since 2012
Who owns Trevi Therapeutics, Inc.
As filed with the SECHolders of 5% or more
4
New Enterprise Associates 16, L.P. holds 10.5% of Common Stock, $0.001 par value per share, as its SCHEDULE 13D/A filed May 7, 2026 says.
Directors and officers
12
report now, of 22 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
New Enterprise Associates 16, L.P.
SCHEDULE 13D/A · filed May 7, 2026 · Common Stock, $0.001 par value per share · 11.6% in Feb 13, 2026
Fmr LLC
SCHEDULE 13G/A · filed Aug 6, 2026 · COMMON STOCK · 6.3% in May 6, 2026
Frazier Life Sciences Public Fund, L.P.
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, $0.001 par value per share · 10.6% in May 15, 2025
Blackrock, Inc.
SCHEDULE 13G/A · filed Oct 27, 2026 · Common Stock · 5.6% in Oct 17, 2025
Viking Global Investors LP
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, $0.001 par value per share · reported falling below 5%, from 5.9% in Aug 14, 2025
Rubric Capital Management LP
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, $0.001 par value per share · reported falling below 5%, from 7.12% in Jul 9, 2025
MAI Capital Management
SCHEDULE 13G/A · filed Jul 10, 2024 · Common Shares · reported falling below 5%
Venrock Healthcare Capital Partners II, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, $0.001 par value · reported falling below 5%
Rosalind Advisors, Inc.
SCHEDULE 13G/A · filed Feb 13, 2025 · Common Shares · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 5.01% in Jan 30, 2026
What TRVI reports owning in othersstakes of 5% or more, and other ties
Trevi Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
4sales
0purchases
4sales on a scheduled plan
1people selling
$600,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 42 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Heffernan Michael Thomas | director | 4 | $600,000 | 4 | 0 | $0 |